Brainstorm Cell Therapeutics Inc. Soared
Tue, Nov 22, 2022 at 07:25 PM
Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ) soared at $1.95, a gain of 30%. The stock appeared on our News Catalysts scanner on Thu, Nov 17, 2022 at 12:14 PM in the 'BIOTECH' category. From Tue, Nov 08, 2022, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Mon, Aug 15, 2022 at $4.7 with a volume of 1M+.
About Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ)
Brainstorm Cell Therapeutics Inc is a biotechnology company. The Company develops novel adult stem cell therapies for debilitating neurodegenerative disorders such as ALS, MS, and PD among others.
Top 10 Gainers:
- Palisade Bio Inc. (PALI:NASDAQ), 81.08%
- Motorsport Games Inc. (MSGM:NASDAQ), 51.11%
- FOXO Technologies Inc. Class A (FOXO:NYSEMKT), 47.57%
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 34.31%
- XL Group Ltd (XL:NYSE), 30.91%
- Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ), 30%
- Digital Brands Group Inc. (DBGI:NASDAQ), 28.53%
- Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT), 28.32%
- Draganfly Inc. (DPRO:NASDAQ), 27.19%
- GH Research PLC (GHRS:NASDAQ), 25.86%